OpenURL Connection Search

Select item for more details and to access through your institution.

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice.
Published in:
PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069193
By:
- Tan, Sih Min;
- Sharma, Arpeeta;
- Yuen, Derek Y. C.;
- Stefanovic, Nada;
- Krippner, Guy;
- Mugesh, Govindasamy;
- Chai, Zhonglin;
- de Haan, Judy B.
Publication type:
Article
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease.
Published in:
Diabetes, 2014, v. 63, n. 9, p. 3091, doi. 10.2337/db13-1743
By:
- Sih Min Tan;
- Sharma, Arpeeta;
- Stefanovic, Nada;
- Yuen, Derek Y. C.;
- Karagiannis, Tom C.;
- Meyer, Colin;
- Ward, Keith W.;
- Cooper, Mark E.;
- de Haan, Judy B.
Publication type:
Article
Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse.
Published in:
Diabetes, 2010, v. 59, n. 12, p. 3198, doi. 10.2337/db10-0195
By:
- Chew, Phyllis;
- Yuen, Derek Y. C.;
- Stefanovic, Nada;
- Pete, Josefa;
- Coughlan, Melinda T.;
- Jandeleit-Dahm, Karin A.;
- Thomas, Merlin C.;
- Rosenfeldt, Franklin;
- Cooper, Mark E.;
- de Haan, Judy B.
Publication type:
Article
Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression.
Published in:
2009
By:
- Yuen DY;
- Dwyer RM;
- Matthews VB;
- Zhang L;
- Drew BG;
- Neill B;
- Kingwell BA;
- Clark MG;
- Rattigan S;
- Febbraio MA;
- Yuen, Derek Y C;
- Dwyer, Renee M;
- Matthews, Vance B;
- Zhang, Lei;
- Drew, Brian G;
- Neill, Bronwyn;
- Kingwell, Bronwyn A;
- Clark, Michael G;
- Rattigan, Stephen;
- Febbraio, Mark A
Publication type:
journal article
Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor-α Expression.
Published in:
Diabetes, 2009, v. 58, n. 5, p. 1086, doi. 10.2337/db08-0775
By:
- Yuen, Derek Y. C.;
- Dwyer, Renee M.;
- Matthews, Vance B.;
- Lei Zhang;
- Drew, Brian G.;
- Neill, Bronwyn;
- Kingwell, Bronwyn A.;
- Clark, Michael G.;
- Rattigan, Stephen;
- Febbraio, Mark A.
Publication type:
Article

Found: 5

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice.

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease.

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse.

Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression.

Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor-α Expression.